Treatment symptomatic of the crisis, dizzy.

In the adult

1.5 to 2 g per day, ie 3 to 4 tablets per day, in two doses morning and evening.
The duration of treatment varies, depending on the clinical course (between 10 days and 5 to 6 weeks), at the beginning of the treatment or in case of unsuccess, the dosage may be increased, without disadvantage up to 3 g Even 4 g per day.

Administration mode

Oral use.

White tablet, biconvex and elongated form.

Class: Pharmacotherapeutic: ANTIVERTIGINOUS MECHANISM, UNKNOWN

ATC Code: N07CA04

Not applicable.

ยท Hypersensitivity to acetylleucine or to any of the excipients

Not applicable.

Not applicable.

Not applicable.

Not applicable.

In view of the available data, it is preferable, as a precautionary measure, not to use acetylleucine during pregnancy regardless of the term.

Indeed, the clinical data are reassuring but still limited and the animal data do not make it possible to conclude.

In the absence of available data, it is preferable not to use acetylleucine during breastfeeding

Very rarely: rashes, skin (sometimes associated with pruritus), urticaria

Treatment symptomatic of the crisis, dizzy.